In canine urothelial carcinoma, HER2 was evaluated with both immunohistochemistry for protein expression and PCR for the copy number aberration status [21]; in another study on canine apocrine anal sac gland carcinomas, the authors demonstrated both HER2 mRNA and protein expression [19]. This evidence concerns the gene ERBB2 and urothelial carcinoma.